Profarma Distribuidora de Produtos Farmacêuticos S.A.

BOVESPA:PFRM3 株式レポート

時価総額:R$680.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Profarma Distribuidora de Produtos Farmacêuticos 過去の業績

過去 基準チェック /56

Profarma Distribuidora de Produtos Farmacêuticosは、平均年間30.3%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間12.9% 14.9%収益成長率で 成長しています。 Profarma Distribuidora de Produtos Farmacêuticosの自己資本利益率は5.6%であり、純利益率は0.9%です。

主要情報

25.5%

収益成長率

25.5%

EPS成長率

Healthcare 業界の成長11.6%
収益成長率14.7%
株主資本利益率6.3%
ネット・マージン1.0%
次回の業績アップデート30 Oct 2024

最近の業績更新

Shareholders Will Be Pleased With The Quality of Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Earnings

Aug 14
Shareholders Will Be Pleased With The Quality of Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Earnings

Recent updates

Shareholders Will Be Pleased With The Quality of Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Earnings

Aug 14
Shareholders Will Be Pleased With The Quality of Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Earnings

Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings

Mar 01
Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings

These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively

Feb 21
These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively

Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)

Nov 04
Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)

Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist

Aug 03
Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist

These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively

Jun 08
These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively

These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively

Sep 26
These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively

Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth

Jan 01
Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth

Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load

May 28
Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load

Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger

May 07
Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger

How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?

Mar 10
How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?

Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 02
Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?

Jan 05
Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?

What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?

Dec 10
What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?

収支内訳

Profarma Distribuidora de Produtos Farmacêuticos の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

BOVESPA:PFRM3 収益、費用、利益 ( )BRL Millions
日付収益収益G+A経費研究開発費
30 Jun 249,038911,1110
31 Mar 248,889771,0760
31 Dec 238,662701,0460
30 Sep 238,550471,0850
30 Jun 238,291311,0530
31 Mar 238,087829880
31 Dec 227,816819170
30 Sep 227,435877540
30 Jun 227,031967300
31 Mar 226,661636910
31 Dec 216,413786670
30 Sep 216,199956440
30 Jun 215,891996080
31 Mar 215,579605800
31 Dec 205,481525680
30 Sep 205,281445540
30 Jun 205,218165610
31 Mar 205,104215680
31 Dec 194,801125550
30 Sep 194,677-55680
30 Jun 194,513-135810
31 Mar 194,388-125900
31 Dec 184,271-106060
30 Sep 184,066-376110
30 Jun 184,009-656150
31 Mar 184,046-916360
31 Dec 174,101-1136530
30 Sep 174,223-1266480
30 Jun 174,195-1006110
31 Mar 174,149-675610
31 Dec 164,085-495050
30 Sep 163,858-184450
30 Jun 163,780-144150
31 Mar 163,619-233870
31 Dec 153,465-213580
30 Sep 153,471-343550
30 Jun 153,392-483480
31 Mar 153,430-463530
31 Dec 143,449-523640
30 Sep 143,439-373790
30 Jun 143,455-113700
31 Mar 143,45603530
31 Dec 133,470203330
30 Sep 133,453332950

質の高い収益: PFRM3は 高品質の収益 を持っています。

利益率の向上: PFRM3の現在の純利益率 (1%)は、昨年(0.4%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: PFRM3過去 5 年間で収益を上げており、収益は年間30.3%増加しています。

成長の加速: PFRM3の過去 1 年間の収益成長率 ( 194.9% ) は、5 年間の平均 ( 年間25.5%を上回っています。

収益対業界: PFRM3の過去 1 年間の収益成長率 ( 194.9% ) はHealthcare業界63.3%を上回りました。


株主資本利益率

高いROE: PFRM3の 自己資本利益率 ( 5.6% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘